Intellectual Property India Publishes Patent Application for 'Lentiviral Particles Displaying Fusion Molecules And Uses Thereof' Filed by Umoja Biopharma, Inc.

MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202517053790 A) filed by Umoja Biopharma, Inc., Seattle, on June 3, for 'lentiviral particles displaying fusion molecules and uses thereof.'

Inventor(s) include Nicolai, Christopher; Tang, Weiliang; Ryu, Byoung; Larson, Ryan; Qin, Jim; Leung, Wai-Hang; Park, Lisa, Yun; and Mittelsteadt, Kristen.

The application for the patent was published on June 27, under issue no. 26/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are particles comprising polynucleotide constructs for generating cells expressing anti-CD19 chimeric antigen receptor, as well as vectors, such as lentiviral vectors, comprising same, cells comprising same, and methods of using same."

The patent application was internationally filed on Nov. 03, 2023, under International application No.PCT/US2023/078732.

Disclaimer: Curated by HT Syndication.